Cargando…

Who cares about migraine? Pathways and hurdles in the European region - access to care III

BACKGROUND: Migraine is a highly prevalent primary headache disorder and a leading cause of disability. Difficulties in access to care during diagnostic and therapeutic journey contribute to the disease burden. Several target-specific drugs have reached the market in the past four years and have mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaghi, Gloria, De Icco, Roberto, Tassorelli, Cristina, Goadsby, Peter J., Vicente-Herrero, Teófila, de la Torre, Elena Ruiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472594/
https://www.ncbi.nlm.nih.gov/pubmed/37653377
http://dx.doi.org/10.1186/s10194-023-01652-8
_version_ 1785100111390441472
author Vaghi, Gloria
De Icco, Roberto
Tassorelli, Cristina
Goadsby, Peter J.
Vicente-Herrero, Teófila
de la Torre, Elena Ruiz
author_facet Vaghi, Gloria
De Icco, Roberto
Tassorelli, Cristina
Goadsby, Peter J.
Vicente-Herrero, Teófila
de la Torre, Elena Ruiz
author_sort Vaghi, Gloria
collection PubMed
description BACKGROUND: Migraine is a highly prevalent primary headache disorder and a leading cause of disability. Difficulties in access to care during diagnostic and therapeutic journey contribute to the disease burden. Several target-specific drugs have reached the market in the past four years and have modified the treatment paradigm in migraine. The aim of this study is to provide an updated snapshot of the pathways and hurdles to care for migraine in different European countries by directly asking patients. METHODS: In 2021 the European Migraine and Headache Alliance proposed a 39-item questionnaire that was administered online to an adult migraine population in European countries. Questions were focused on socio-demographic and migraine data, access to diagnosis and treatment, disease-related burden and the main channel for disease information. RESULTS: A total of 3169 questionnaires were returned from 10 European countries. Responders were predominantly females, age range 25–59 years, with a migraine history longer than 10 years in 82% of cases, and with at least 8 headache days per month in 57% of cases. Respondents reported limitations in social, working and personal life during both the ictal and interictal phase. The activities mostly impaired during the attacks were driving (55%), cooking or eating (42%), taking care of family/childcare (40%) and getting medicines at the pharmacy (40%). The most frequently reported unmet need was the long delay between the first visit and migraine diagnosis: 34% of respondents had to see ≥ 4 specialists before being correctly diagnosed, and between the diagnosis and treatment prescription: > 5 years in 40% of cases. The most relevant needs in terms of quality of life were the desire for a lower migraine frequency, an effective treatment and a greater involvement in society. CONCLUSIONS: Data from the present survey point to the existence and persistence of multiple hurdles that result in significant limitations to access to care and to the patients’ social life. A close cooperation between decision makers, healthcare workers and patients is needed to overcome these barriers. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10194-023-01652-8.
format Online
Article
Text
id pubmed-10472594
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-104725942023-09-02 Who cares about migraine? Pathways and hurdles in the European region - access to care III Vaghi, Gloria De Icco, Roberto Tassorelli, Cristina Goadsby, Peter J. Vicente-Herrero, Teófila de la Torre, Elena Ruiz J Headache Pain Research BACKGROUND: Migraine is a highly prevalent primary headache disorder and a leading cause of disability. Difficulties in access to care during diagnostic and therapeutic journey contribute to the disease burden. Several target-specific drugs have reached the market in the past four years and have modified the treatment paradigm in migraine. The aim of this study is to provide an updated snapshot of the pathways and hurdles to care for migraine in different European countries by directly asking patients. METHODS: In 2021 the European Migraine and Headache Alliance proposed a 39-item questionnaire that was administered online to an adult migraine population in European countries. Questions were focused on socio-demographic and migraine data, access to diagnosis and treatment, disease-related burden and the main channel for disease information. RESULTS: A total of 3169 questionnaires were returned from 10 European countries. Responders were predominantly females, age range 25–59 years, with a migraine history longer than 10 years in 82% of cases, and with at least 8 headache days per month in 57% of cases. Respondents reported limitations in social, working and personal life during both the ictal and interictal phase. The activities mostly impaired during the attacks were driving (55%), cooking or eating (42%), taking care of family/childcare (40%) and getting medicines at the pharmacy (40%). The most frequently reported unmet need was the long delay between the first visit and migraine diagnosis: 34% of respondents had to see ≥ 4 specialists before being correctly diagnosed, and between the diagnosis and treatment prescription: > 5 years in 40% of cases. The most relevant needs in terms of quality of life were the desire for a lower migraine frequency, an effective treatment and a greater involvement in society. CONCLUSIONS: Data from the present survey point to the existence and persistence of multiple hurdles that result in significant limitations to access to care and to the patients’ social life. A close cooperation between decision makers, healthcare workers and patients is needed to overcome these barriers. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10194-023-01652-8. Springer Milan 2023-09-01 /pmc/articles/PMC10472594/ /pubmed/37653377 http://dx.doi.org/10.1186/s10194-023-01652-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Vaghi, Gloria
De Icco, Roberto
Tassorelli, Cristina
Goadsby, Peter J.
Vicente-Herrero, Teófila
de la Torre, Elena Ruiz
Who cares about migraine? Pathways and hurdles in the European region - access to care III
title Who cares about migraine? Pathways and hurdles in the European region - access to care III
title_full Who cares about migraine? Pathways and hurdles in the European region - access to care III
title_fullStr Who cares about migraine? Pathways and hurdles in the European region - access to care III
title_full_unstemmed Who cares about migraine? Pathways and hurdles in the European region - access to care III
title_short Who cares about migraine? Pathways and hurdles in the European region - access to care III
title_sort who cares about migraine? pathways and hurdles in the european region - access to care iii
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472594/
https://www.ncbi.nlm.nih.gov/pubmed/37653377
http://dx.doi.org/10.1186/s10194-023-01652-8
work_keys_str_mv AT vaghigloria whocaresaboutmigrainepathwaysandhurdlesintheeuropeanregionaccesstocareiii
AT deiccoroberto whocaresaboutmigrainepathwaysandhurdlesintheeuropeanregionaccesstocareiii
AT tassorellicristina whocaresaboutmigrainepathwaysandhurdlesintheeuropeanregionaccesstocareiii
AT goadsbypeterj whocaresaboutmigrainepathwaysandhurdlesintheeuropeanregionaccesstocareiii
AT vicenteherreroteofila whocaresaboutmigrainepathwaysandhurdlesintheeuropeanregionaccesstocareiii
AT delatorreelenaruiz whocaresaboutmigrainepathwaysandhurdlesintheeuropeanregionaccesstocareiii